Mimedx (MDXG) Assets Average (2011 - 2026)
Mimedx's (MDXG) quarterly Assets Average came in at $325.7 million in Q1 2026, up 21.9% year-on-year from $267.2 million in Q1 2025, and down 1.56% quarter-over-quarter from $330.8 million in Q4 2025.
Mimedx (MDXG) Assets Average (2011 - 2026) Analysis & Trends
Mimedx has disclosed Assets Average across 15 years of filings, most recently posting $325.7 million for Q1 2026.
- Assets Average for Q1 2026 came in at $325.7 million, up 21.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.7 million (up 21.9% YoY), and the FY2025 annual result was $303.3 million, up 20.6% from the prior year.
- Assets Average came in at $325.7 million for Q1 2026 at Mimedx, down from $330.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $330.8 million in Q4 2025 to a low of $169.8 million in Q1 2023.
- The 5-year median for Assets Average is $225.9 million (2024), against an average of $228.9 million.
- Across the five-year window, Assets Average declined 9.22% in 2022 and soared 35.67% in 2024, its largest moves.
- Mimedx's Assets Average stood at $172.1 million in 2022, then increased by 24.36% to $214.0 million in 2023, then grew by 18.63% to $253.9 million in 2024, then jumped by 30.29% to $330.8 million in 2025, then slipped by 1.56% to $325.7 million in 2026.
- The last three Assets Average figures came in at $325.7 million (Q1 2026), $330.8 million (Q4 2025), and $305.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 325.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.66 Mn |
| Dec 31, 2025 | 330.82 Mn |
| Sep 30, 2025 | 305.05 Mn |
| Jun 30, 2025 | 280.76 Mn |
| Mar 31, 2025 | 267.17 Mn |
| Dec 31, 2024 | 253.90 Mn |
| Sep 30, 2024 | 237.04 Mn |
| Jun 30, 2024 | 225.93 Mn |
| Mar 31, 2024 | 230.36 Mn |
| Dec 31, 2023 | 214.03 Mn |
| Sep 30, 2023 | 182.70 Mn |
| Jun 30, 2023 | 172.27 Mn |
| Mar 31, 2023 | 169.79 Mn |
| Dec 31, 2022 | 172.11 Mn |
| Sep 30, 2022 | 170.73 Mn |
| Jun 30, 2022 | 171.56 Mn |
| Mar 31, 2022 | 181.19 Mn |
| Dec 31, 2021 | 184.23 Mn |
| Sep 30, 2021 | 183.84 Mn |
| Jun 30, 2021 | 188.98 Mn |